Does EPOPROSTENOL Cause Pulmonary arterial hypertension? 1,055 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,055 reports of Pulmonary arterial hypertension have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 7.9% of all adverse event reports for EPOPROSTENOL.
1,055
Reports of Pulmonary arterial hypertension with EPOPROSTENOL
7.9%
of all EPOPROSTENOL reports
475
Deaths
864
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From EPOPROSTENOL?
Of the 1,055 reports, 475 (45.0%) resulted in death, 864 (81.9%) required hospitalization, and 58 (5.5%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 1,055 reports have been filed with the FAERS database.
What Other Side Effects Does EPOPROSTENOL Cause?
Dyspnoea (2,744)
Headache (2,425)
Diarrhoea (2,310)
Nausea (2,016)
Pain in jaw (1,928)
Death (1,362)
Flushing (1,256)
Fatigue (1,133)
Hospitalisation (1,078)
Vomiting (1,068)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)
BOSENTAN\BOSENTAN (245)
Which EPOPROSTENOL Alternatives Have Lower Pulmonary arterial hypertension Risk?
EPOPROSTENOL vs EPTIFIBATIDE
EPOPROSTENOL vs EPTINEZUMAB-JJMR
EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR
EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2
EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN